← Back to June 2017


2017 Annual Pharmacy Update: Continuing Progress and Forging Ahead


links image

Adam Cochrane, PharmD, BCPS
Pharmacy & Pharmacology Council Chair
Inova Fairfax Hospital
Falls Church, VA, USA
Adam.Cochrane@inova.org



As I take over as Chair of the Pharmacy and Pharmacology Council, I am happy to see where we stand from where we started, with both events (the start of the council and taking over as Chair) occurring in San Diego. The council has grown and the council's involvement within the society has grown and continues to grow.

This year's Meeting in San Diego was amazing as the Pharmacy and Pharmacology Council sponsored talk on the Highs and Lows of Marijuana had over 200 people in the room, and the moderators were the only ones able to take care of their munchies during the session. We also sponsored a Lifecycle symposium covering the highs and lows of thrombosis in MCS - which really are mostly lows... Again, this year pharmacists were able to obtain CE at the meeting with a maximum of 18.5 hours available. The pharmacology CE will also count for APNs in the United States, and nurses who are renewing Certified Clinical Transplant Coordinator credentials. Additionally, the pharmacy council has secured ACPE CE credit for the next 10 years. When looking around the meeting, we are seeing members of our council as moderators and speakers in other council's symposia, which is gratifying to see our council's growth and inclusion within the Society.

Mike Shullo and Robert Page are leading an effort to further call attention to standards pertaining to the practice of Thoracic Transplant Pharmacy, which highlights our core competencies document (which is available on the council's webpage) and is an informative read for practices that don't have a pharmacist as part of their team, or regions of the world that want to implement pharmacist involvement in their clinical practice.

With no definitive document discussing immunosuppressant use in heart or lung transplantation - considerations of generics, approved vs. accepted use in U.S. and globally, and considerations of payment (insurance and national formulary considerations) - the Pharmacy and Pharmacology Council has taken the lead in creating a consensus document on immunomodulating agents in thoracic transplantation. The working groups met and started work in San Diego and are working toward a document that will be completed and available in the beginning of 2018. I would like to thank all the people across the Society that have volunteered and worked on this project.

It is my privilege to serve as chair of this council, and I look forward to the next two years as such. I believe that the above projects are only the start of the larger impact this council can have on and within the Society. ■

Disclosure Statement: The author has no conflicts of interest to disclose.




Share via:

links image    links image    links image    links image